Small Molecules
29 August 2014
BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease29 August 2014
Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia28 August 2014
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure26 August 2014
Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain25 August 2014
Alkermes Submits New Drug Application to FDA for Aripiprazole Lauroxil for Treatment of Schizophrenia22 August 2014
Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer22 August 2014
Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review21 August 2014
European Medicines Agency accepts Basilea’s isavuconazole Marketing Authorization Application for review21 August 2014
GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma20 August 2014
KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema20 August 2014
FDA Approves Genzyme’s Cerdelga™ (eliglustat) CapsulesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports